ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,461,092, issued on Nov. 4, was assigned to SHIMADZU Corp. (Kyoto, Japan) and THE UNIVERSITY OF TOKYO (Tokyo).
"Screening method for APP cleavage activity-controlling substances of ADAMTS4" was invented by Naoki Kaneko (Kyoto, Japan), Taisuke Tomita (Tokyo), Yota Yoshizawa (Tokyo), Masaya Matsuzaki (Tokyo) and Miyabishara Yokoyama (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for screening a substance that controls APP669 N-terminal cleavage activity, the method comprising: causing a candidate substance to act on a cultured cell; measuring an ABeta-related peptide produced from the cultured cell; and evaluat...